112 filings
Page 4 of 6
8-K
w3g wskqtesz0lf3ha
23 Dec 21
Departure of Directors or Certain Officers
9:00am
424B3
1djsququeuy
20 Dec 21
Prospectus supplement
7:24am
EFFECT
rwmasg286 wdo
20 Dec 21
Notice of effectiveness
12:15am
CORRESP
d1k2l1lq ptxofs
15 Dec 21
Correspondence with SEC
12:00am
UPLOAD
10kglg
15 Dec 21
Letter from SEC
12:00am
D
kljunvs
3 Dec 21
$12.82M in equity / options / securities to be acquired, sold $3.54M, 12 investors
4:16pm
8-K
2yj6oarkcbaa
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
424B5
k0ykwswlvwrc7id8nsk
1 Dec 21
Prospectus supplement for primary offering
5:10pm
EFFECT
fp1bewhet2yh74yt3uy2
24 Nov 21
Notice of effectiveness
12:15am
424B3
dpxb9pj
23 Nov 21
Prospectus supplement
4:11pm
CORRESP
muelh 6qd0x9ekweif
23 Nov 21
Correspondence with SEC
12:00am
DEF 14A
yyekpuih nbwzu
22 Nov 21
Definitive proxy
4:37pm
CORRESP
wxuixihe
22 Nov 21
Correspondence with SEC
12:00am
UPLOAD
jb4pzmna
19 Nov 21
Letter from SEC
12:00am
8-K
d6ju76u2p zfqx
17 Nov 21
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:20pm
8-K
oqgz5wbtzqa2 te3rnwl
16 Nov 21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
12:00am
S-1
syzvzdf c5q10rccp
12 Nov 21
IPO registration
5:03pm
D
fpjykegabds
26 Oct 21
$5.92M in options / securities to be acquired, 10 investors
1:39pm